Clinical Trials

Accrual Status
Limit to SWOG Trials

1047 Results

View
Closed
Phase
Accrual
5%
SWOG Clinical Trial Number
SWOG-9015

A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III
Research Committee(s)
Lung Cancer
Activated
05-15-1992
Closed
03-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9019

A Pilot Study of Chemotherapy Plus Radiation Therapy for Selected IIIb (No Malignant Effusion) Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-15-1992
Closed
12-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9051

Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1992
Closed
04-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9035

Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.
Research Committee(s)
Melanoma
Activated
04-15-1992
Closed
11-15-1996
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-9137

Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin® (Porfimer Sodium) in the Therapeutic and Prophylactic Management of Transitional Cell Carcinoma of the Bladder
Activated
03-15-1992
Closed
12-01-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9151

Evaluation of Topotecan in Hepatoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-1992
Closed
06-15-1993
Closed
Phase
Accrual
14%
SWOG Clinical Trial Number
SWOG-9115 (EST-1192) (INT-0127)

Randomized Study of Standard Chemotherapy vs. STAMP V with Autologous Stem Cell Infusion in Stage IV Poor Prognosis Breast Carcinoma, Phase III, a BMT Study (Intergroup)
Activated
02-01-1992
Closed
01-01-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9139

Adjuvant Therapy of Primary Osteogenic Sarcomas, Phase II
Activated
12-15-1991
Closed
12-01-1996
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-9119

Primary Chemotherapy of Poor Prognosis Soft Tissue Sarcomas, Phase II
Activated
12-15-1991
Closed
06-15-1998
Closed
Phase
Accrual
64%
Published
SWOG Clinical Trial Number
SWOG-9136

Biologic Parameters in Soft Tissue Sarcomas: A Companion Study to Select Southwest Oncology Group Clinical Trials with Soft Tissue Sarcoma Patients
Research Committee(s)
Sarcoma
Activated
12-15-1991
Closed
06-15-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9031

A Double Blind Placebo Controlled Trial of Daunomycin and Cytosine Arabinoside With or Without rhG-CSF in Elderly Patients With Acute Myeloid Leukemia
Research Committee(s)
Leukemia
Activated
11-15-1991
Closed
01-15-1995
Closed
Phase
Accrual
18%
Published
SWOG Clinical Trial Number
SWOG-9118

Chemotherapy with FAMTX in Gastric Cancer or FMTX in Colorectal Cancer: Assessment of Pharmacodynamics with Magnetic Resonance Spectroscopy, Cellular Biochemical Pharmacology, and Cellular Pathology, Phase II
Activated
11-15-1991
Closed
11-15-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9110

A Phase II Evaluation of Didemnin B In Central Nervous System Tumors
Research Committee(s)
Brain Cancer
Activated
11-01-1991
Closed
11-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9060

A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
11-01-1991
Closed
03-01-1993
Closed
Phase
Accrual
60%
Published
SWOG Clinical Trial Number
SWOG-9030

Phase II Study of High Dose ARA-C/Mitoxantrone for the Treatment of Relapsed/Refractory Acute Lymphocytic Leukemia
Research Committee(s)
Leukemia
Activated
11-01-1991
Closed
05-15-1994
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8913

Evaluation of Merbarone in Malignant Melanoma, Phase II
Activated
09-01-1991
Closed
06-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Trial of Adjuvant Chemoradiation After Gastric Resection For Adenocarcinoma, Phase III
Research Committee(s)
Gastrointestinal Cancer
Activated
08-01-1991
Closed
07-15-1998
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9024

A Pilot Study of Combined Modality Therapy in T3, 4; N0, M0 Adenocarcinoma of the Prostate, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
08-01-1991
Closed
03-15-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9127

Evaluation of Cisplatin, Carboplatin and Etoposide in Selected Stage IIIb and Stage IV Non-Small Cell Lung Carcinoma, Phase II
Research Committee(s)
Lung Cancer
Activated
08-01-1991
Closed
03-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9062

Evaluation of 96 Hour Infusion 5-FU + Cisplatin + Alpha Interferon in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
08-01-1991
Closed
10-01-1993